1. Home
  2. CAI

as of 02-25-2026 4:00pm EST

$18.39
+$0.19
+1.04%
Stocks Health Care Medical Specialities Nasdaq

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Founded: 2008 Country:
United States
United States
Employees: N/A City: IRVING
Market Cap: 6.0B IPO Year: N/A
Target Price: $33.63 AVG Volume (30 days): 2.2M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $17.15 - $42.50 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 83.89% Revenue Growth (next year): 31.68%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered CAI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 91.67%
91.67%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Caris Life Sciences Inc. News

CAI Breaking Stock News: Dive into CAI Ticker-Specific Updates for Smart Investing

All CAI News

Share on Social Networks: